Corporate AI safety research clusters pre-deployment, leaving high-risk domains underexamined, SSRC finds in 1,178-paper study
What happened
The Social Science Research Council published Real-World Gaps in AI Governance Research, an analysis of 1,178 AI safety and reliability papers published between January 2020 and March 2025. The study examined research output from major corporate AI labs including Anthropic, Google DeepMind, Meta, Microsoft, and OpenAI, as well as academic institutions such as Stanford. The findings show that corporate AI research is heavily concentrated on pre-deployment activities such as alignment and evaluation, while attention to deployment-stage issues including algorithmic bias has declined as commercial pressures have intensified. Identified research gaps are most pronounced in high-risk domains including healthcare, finance, misinformation, hallucinations, and copyright. The study was conducted under US jurisdiction and raises direct concerns about whether vendor-published safety research adequately addresses risks that emerge once AI systems are integrated into production environments.
Why it matters
- ·Regulators in both the US and internationally are increasingly focused on ongoing post-deployment risk management obligations, meaning organizations that rely solely on vendor pre-deployment safety research may face heightened regulatory exposure in audits or enforcement actions.
- ·Enterprise deployments in regulated sectors such as healthcare and financial services introduce variables including novel user populations and sensitive data integration that pre-deployment laboratory research does not replicate, creating operational gaps that published vendor safety claims will not cover.
- ·Organizations that defer to upstream vendor research without maintaining independent post-deployment monitoring and bias audit records face organizational risk if AI-related incidents occur in high-stakes domains, as documentation of due diligence will be difficult to produce.
Governance controls affected
What to do now
- ☐Review third-party AI risk assessments for healthcare and financial services deployments to verify they do not rely exclusively on vendor-published pre-deployment safety research.
- ☐Implement or audit post-deployment bias and fairness monitoring programs for AI systems used in high-stakes regulated decisions, ensuring coverage of hallucination rates, algorithmic bias, and domain-specific risk indicators.
- ☐Document the known limitations of vendor safety claims in third-party risk management records, particularly for systems subject to regulatory scrutiny in healthcare or financial services.
- ☐Schedule independent adversarial testing and domain-specific bias audits for production AI systems operating in the high-risk domains identified by the SSRC study: healthcare, finance, misinformation, and copyright.
- ☐Establish a process to track whether AI vendors expand their post-deployment research disclosures over time and flag material gaps as part of ongoing vendor contract reviews.
What to watch next
Compliance teams should monitor whether US and international regulators issue guidance that explicitly requires post-deployment validation evidence independent of vendor safety research, particularly in healthcare and financial services. The SSRC findings may be cited in upcoming rulemaking or supervisory guidance as evidence that pre-deployment research is insufficient for regulated use cases. Teams should also track whether major AI vendors respond to this study by expanding their post-deployment research programs or updating model cards and documentation to address the identified gaps. Enforcement patterns in the EU AI Act's high-risk category rollout will provide an early signal of how regulators expect organizations to close the pre-deployment versus post-deployment research gap.